全文获取类型
收费全文 | 9493篇 |
免费 | 976篇 |
国内免费 | 353篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 319篇 |
妇产科学 | 111篇 |
基础医学 | 1877篇 |
口腔科学 | 201篇 |
临床医学 | 880篇 |
内科学 | 1653篇 |
皮肤病学 | 199篇 |
神经病学 | 798篇 |
特种医学 | 134篇 |
外国民族医学 | 3篇 |
外科学 | 671篇 |
综合类 | 956篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 702篇 |
眼科学 | 368篇 |
药学 | 845篇 |
8篇 | |
中国医学 | 403篇 |
肿瘤学 | 646篇 |
出版年
2024年 | 35篇 |
2023年 | 207篇 |
2022年 | 325篇 |
2021年 | 522篇 |
2020年 | 461篇 |
2019年 | 438篇 |
2018年 | 369篇 |
2017年 | 405篇 |
2016年 | 379篇 |
2015年 | 397篇 |
2014年 | 562篇 |
2013年 | 735篇 |
2012年 | 460篇 |
2011年 | 506篇 |
2010年 | 425篇 |
2009年 | 416篇 |
2008年 | 383篇 |
2007年 | 387篇 |
2006年 | 398篇 |
2005年 | 322篇 |
2004年 | 321篇 |
2003年 | 274篇 |
2002年 | 256篇 |
2001年 | 228篇 |
2000年 | 177篇 |
1999年 | 174篇 |
1998年 | 153篇 |
1997年 | 128篇 |
1996年 | 133篇 |
1995年 | 92篇 |
1994年 | 87篇 |
1993年 | 81篇 |
1992年 | 67篇 |
1991年 | 62篇 |
1990年 | 48篇 |
1989年 | 52篇 |
1988年 | 41篇 |
1987年 | 37篇 |
1986年 | 29篇 |
1985年 | 54篇 |
1984年 | 39篇 |
1983年 | 28篇 |
1982年 | 32篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 17篇 |
1978年 | 10篇 |
1977年 | 13篇 |
1976年 | 6篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
ObjectiveTo investigate the presence of symptoms of moral injury in obstetric and neonatal nurses.DesignA secondary qualitative analysis using an analytic expansion of three primary studies.SettingPostal mail and electronic surveys.ParticipantsI used three primary studies: participants in the first consisted of 78 labor and delivery nurses, participants in the second consisted of 75 nurse-midwives, and participants in the third consisted of 22 NICU nurses.MethodsI used Krippendorff’s content analysis method for qualitative data to reanalyze the three primary data sets. The categories I used in this analysis were the 10 symptoms of moral injury that are assessed by the Moral Injury Symptoms Scale–Health Professionals Version.ResultsWhen combining the three types of obstetric and neonatal participants, the top three most frequently cited symptoms of moral injury were moral concern, guilt, and self-condemnation. For participants in labor and delivery units and NICUs, moral concern was the most often described symptom, whereas for participants in midwifery it was guilt. None of the participants reported loss of meaning in their lives, loss of faith, or religious struggle. Participants who worked in NICUs did not describe any symptoms of shame or difficulty forgiving.ConclusionIn addition to the primary symptoms of moral injury, reported secondary consequences of moral injury can include depression, anxiety, anger, self-harm, and social problems. Interventions such as acceptance and commitment therapy are needed to help nurses address the potential for moral injury and repair its effects. Since the COVID-19 pandemic, now more than ever, moral injury needs to be recognized in obstetric and neonatal nurses and not just in the military population. 相似文献
4.
Jeffrey J. Silbiger 《Echocardiography (Mount Kisco, N.Y.)》2019,36(5):954-957
Secondary tricuspid regurgitation (TR) caused by right ventricular enlargement in the setting of left heart disease/pulmonary hypertension has been well described. In contrast, that associated with right atrial enlargement—atrial functional TR (AF‐TR)—remains largely underappreciated. AF‐TR most often occurs in the setting of lone atrial fibrillation, although it is also seen in its absence (idiopathic AF‐TR). Several recent studies have found that the prevalence, hemodynamic significance, and prognosis of AF‐TR are not inconsequential, suggesting increased physician awareness of this novel clinical entity is warranted. This article discusses the pathogenesis, echocardiographic findings, and treatment of this underappreciated cause of secondary TR. 相似文献
5.
6.
7.
8.
Sameer Arora Kamal Shemisa Muthiah Vaduganathan Arman Qamar Ankur Gupta Sushil K. Garg Dharam J. Kumbhani Helen Mayo Houman Khalili Ambarish Pandey Sandeep R. Das 《Journal of the American College of Cardiology》2019,73(19):2454-2464
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects such as bleeding and dyspnea have been associated with premature ticagrelor discontinuation, which may limit any potential advantage of ticagrelor over clopidogrel. The randomized trials of ticagrelor captured adverse events, offering the opportunity to more precisely quantify these effects across studies. Therefore, a meta-analysis of 4 randomized clinical trials of ticagrelor conducted between January 2007 and June 2017 was performed to quantify the incidence and causes of premature ticagrelor discontinuation. Among 66,870 patients followed for a median 18 months, premature ticagrelor discontinuation was seen in 25%; bleeding was the most common cause of discontinuation followed by dyspnea. Versus the comparators, the relative risk of dyspnea-related discontinuation during follow-up was 6.4-fold higher, the relative risk of bleeding was 3.2-fold higher, and the relative risk of discontinuation due to any adverse event was 59% higher for patients receiving ticagrelor. Understanding these potential barriers to adherence to ticagrelor is crucial for informed patient-physician decision making and can inform future efforts to improve ticagrelor adherence. This review discusses the incidence, causes, and biological mechanisms of ticagrelor-related adverse effects and offers strategies to improve adherence to ticagrelor. 相似文献
9.
Nandita M deSouza Clare M Tempany 《International journal of cancer. Journal international du cancer》2019,144(3):422-430
Recognition of <3 metastases in <2 organs, particularly in cancers with a known predisposition to oligometastatic disease (OMD) (colorectal, prostate, renal, sarcoma and lung), offers the opportunity to focally treat the lesions identified and confers a survival advantage. The reliability with which OMD is identified depends on the sensitivity of the imaging technique used for detection and may be predicted from phenotypic and genetic factors of the primary tumour, which determine metastatic risk. Whole-body or organ-specific imaging to identify oligometastases requires optimization to achieve maximal sensitivity. Metastatic lesions at multiple locations may require a variety of imaging modalities for best visualisation because the optimal image contrast is determined by tumour biology. Newer imaging techniques used for this purpose require validation. Additionally, rationalisation of imaging strategies is needed, particularly with regard to timing of imaging and follow-up studies. This article reviews the current evidence for the use of imaging for recognising OMD and proposes a risk-based roadmap for identifying patients with true OMD, or at risk of metastatic disease likely to be OM. 相似文献